[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"cookie-copy":3,"important-message":10,"onboarding":23,"mainMenu":198,"contribution-page-SE-0-SE-6-16785":199,"footer":584},{"content":4,"modalContent":7},{"en":5,"sv":6},"\u003Cp>Openaid.se uses cookies to improve your experience as a user, including cookies for web analytics and cookies that help the website function properly. Cookies that handle your selection in this box cannot be opted out. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fen\u002Fabout-openaid\u002Fabout-the-website\">Read more about cookies at Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n","\u003Cp>Openaid.se använder kakor för att förbättra upplevelsen för dig som användare, bland annat kakor för webbanalys och kakor som bidrar till att webbplatsen fungerar korrekt. Kakor som hanterar ditt val i denna ruta går inte att välja bort. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fabout-openaid\u002Fabout-the-website\">Läs mer om kakor på Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n",{"en":8,"sv":9},"\u003Cp>Openaid.se use necessary and functional cookies to make our website work. We also use cookies to improve website functionality by obtaining statistics on how the site is used. You can change your settings here at any time. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fen\u002Fabout-openaid\u002Fabout-the-website\">Read more\u003C\u002Fa>\u003C\u002Fp>\n","\u003Cp>Här godkänner du vilka kakor webbplatsen får spara i din dator. Du kan när som helst ändra dina inställningar. \u003Ca href=\"https:\u002F\u002Fopenaid.se\u002Fabout-openaid\u002Fabout-the-website\">Läs mer om kakor på Openaid.se\u003C\u002Fa>\u003C\u002Fp>\n",{"data":11,"show":12},{"active":12,"title":13,"message":16,"link":19,"link_text":21,"starttime":22,"endtime":20},false,{"en":14,"sv":15},"The website is currently experiencing technical issues ","Tekniska problem",{"en":17,"sv":18},"We are currently experiencing technical issues and are working to restore the website as soon as possible. Please try again later.\r\n\r\nContact openaid@sida.se for more information.","Vi har just nu tekniska problem och arbetar med att återställa webbplatsen. Försök gärna igen senare.\r\n\r\nKontakta openaid@sida.se vid frågor.\r\n",{"en":20,"sv":20},"",{"en":20,"sv":20},"2026-08-18T10:41:32",{"help":24,"intro":72,"tour":127},{"data":25,"enabled":71},{"page_description":26,"tour_description":51,"intro_description":61},[27,33,39,45],{"page":28,"description":30},{"en":29,"sv":29},"%2Ffind-aid%2Fsector-category",{"en":31,"sv":32},"On this page sector categories are listed and can be filtered by year or search keyword.","På den här sidan listas sektorkategorier, som beskriver vilket specifikt område hos en mottagare som en aktivitet ska gynna och utveckla. Dessa kan filtreras på år och sökord.",{"page":34,"description":36},{"en":35,"sv":35},"%2Ffind-aid%2Fdonors",{"en":37,"sv":38},"On this page responsible government agencies are listed and can be filtered by year or search keyword.","På den här sidan listas ansvariga myndigheter. Dessa kan filtreras på år och sökord.",{"page":40,"description":42},{"en":41,"sv":41},"%2Ffind-aid%2Fcountries-and-regions",{"en":43,"sv":44},"On this page countries and regions are listed.","På den här sidan listas länder och regioner där Sverige bedriver utvecklingssamarbete och där stöd ska bidra till utvecklingsresultat.",{"page":46,"description":48},{"en":47,"sv":47},"%2Ffind-aid%2Fpartners",{"en":49,"sv":50},"Choose a partner that Swedish government agencies cooperate with to implement Swedish aid.","På den här sidan listas samarbetspartner som ansvariga myndigheter samarbetar med för att genomföra biståndet.",{"title":52,"description":55,"button_text":58},{"en":53,"sv":54},"Do you need help?","Vill du ha hjälp att utforska biståndet?",{"en":56,"sv":57},"Join a tour and get tips on what to do on this page.","Följ med på en rundtur med tips på vad du kan göra på denna sida.",{"en":59,"sv":60},"Start the tour","Visa mig runt på sidan",{"title":62,"description":65,"button_text":68},{"en":63,"sv":64},"Do you want to know more about Openaid?","Vill du veta mer om Openaid?",{"en":66,"sv":67},"Here you will get a quick introduction to Openaid and what you can do on this website.","Här får du en snabb introduktion till vad Openaid är och vad du kan göra på webbplatsen.",{"en":69,"sv":70},"Start introduction","Starta introduktionen",true,{"data":73,"enabled":71},[74,82,90,100,110,119],{"title":75,"description":78,"other_info":81},{"en":76,"sv":77},"Welcome to Openaid","Välkommen till Openaid",{"en":79,"sv":80},"Here you will find information about when, to whom and for what purpose Swedish aid funds have been disbursed since 1998. You can also see the results that have been achieved. ","Här kan du se när, till vem och för vilket ändamål svenskt statligt bistånd har betalats ut sedan 1998. Du kan också se biståndets resultat. ",{"en":20,"sv":20},{"title":83,"description":86,"other_info":89},{"en":84,"sv":85},"Openaid shows data from different agencies","Openaid visar data från olika myndigheter",{"en":87,"sv":88},"Statistics and payments from all Swedish government agencies handling funds in the Expenditure area 7: International aid form the basis for the data presented on Openaid.","På Openaid kan du hitta statistik och utbetalningar från alla myndigheter och departement som hanterar statliga biståndsmedel.",{"en":20,"sv":20},{"title":91,"description":94,"other_info":97},{"en":92,"sv":93},"Choose what data you want to see","Välj vilken data du vill se",{"en":95,"sv":96},"You can choose to see data from specific agencies, to specific countries or regions or within specific sectors. You can also see contributions performed by a specific partner.","Du kan välja att se data från vissa myndigheter, till vissa geografiska områden eller inom vissa sektorkategorier, som beskriver vilket temaområde en insats genomförs i. Du kan också se insatser som utförts av en viss samarbetspartner.",{"en":98,"sv":99},"Openaid is continuously updated. This means that for the current and previous year, sums are updated as data is reported and published. ","Openaid uppdateras löpande. Det innebär att för nuvarande år och föregående år uppdateras summor i takt med att data rapporteras in och publiceras. ",{"title":101,"description":104,"other_info":107},{"en":102,"sv":103},"See contributions","Se enskilda biståndsinsatser",{"en":105,"sv":106},"You can get in-depth information about a contribution. Here you can see results, transactions and documents. ","Du kan få fördjupad information om en enskild insats som gjorts inom biståndet. Här kan du se resultat, transaktioner och dokument. ",{"en":108,"sv":109},"The website’s data can be exported. ","All data på Openaid går att exportera. ",{"title":111,"description":113,"other_info":116},{"en":53,"sv":112},"Hjälpen är alltid nära",{"en":114,"sv":115},"Locate the button with a question mark in the lower right corner!","På Openaid finns fler tips på vad du kan göra. Leta upp knappen med frågetecknet i högra hörnet!",{"en":117,"sv":118},"For questions, please contact openaid@sida.se.","Vid frågor, kontakta openaid@sida.se.",{"title":120,"description":123,"other_info":126},{"en":121,"sv":122},"Explore aid","Är du redo att utforska biståndet?",{"en":124,"sv":125},"Start exploring the Swedish development cooperation on Openaid. Either on your own or by joining the tour.","Nu kan du börja utforska biståndet på Openaid – antingen på egen hand eller genom att följa med på en rundtur.",{"en":20,"sv":20},{"data":128,"enabled":71},{"general":129,"startpage":149,"explore_aid":164},[130,140],{"id":131,"title":132,"description":135,"other_info":138},"explore-aid-menu-button",{"en":133,"sv":134},"Find all Swedish aid","Hitta till allt bistånd",{"en":136,"sv":137},"Here you can find data based on responsible agencies, countries and regions, partners, sector categories, strategies and The Sustainable Development Goals. ","Här kan du hitta bistånd utifrån ansvarig myndighet, länder och regioner, samarbetspartner, sektorkategorier, strategier och Globala målen. ",{"en":139,"sv":139},null,{"id":141,"title":142,"description":145,"other_info":148},"main-search",{"en":143,"sv":144},"Search the site","Sök på webbplatsen",{"en":146,"sv":147},"Here you can search for any content on the site, for example a country, a contribution or a document.","Här kan du söka på allt innehåll efter till exempel ett land, en insats eller ett dokument.",{"en":139,"sv":139},[150,159],{"id":151,"title":152,"description":155,"other_info":158},"show-aid-button",{"en":153,"sv":154},"Explore aid on your own","Utforska biståndet på egen hand",{"en":156,"sv":157},"You can choose which responsible agencies you want to see Swedish aid from, to which geographical areas and within which sector categories.","Du kan välja vilka ansvariga myndigheter du vill se bistånd från, till vilka geografiska områden samt inom vilka sektorkategorier. ",{"en":139,"sv":139},{"id":160,"title":161,"description":162,"other_info":163},"more-choices-filter-button",{"en":20,"sv":20},{"en":20,"sv":20},{"en":139,"sv":139},[165,170,175,180,189],{"id":166,"title":167,"description":168,"other_info":169},"comparison-filter-card",{"en":20,"sv":20},{"en":20,"sv":20},{"en":139,"sv":139},{"id":171,"title":172,"description":173,"other_info":174},"comparison-filter-modal-trigger",{"en":20,"sv":20},{"en":20,"sv":20},{"en":139,"sv":139},{"id":176,"title":177,"description":178,"other_info":179},"add-comparison-button",{"en":20,"sv":20},{"en":20,"sv":20},{"en":139,"sv":139},{"id":181,"title":182,"description":185,"other_info":188},"compare-explore-aid-navigation",{"en":183,"sv":184},"See how the aid is distributed","Se hur biståndet är fördelat",{"en":186,"sv":187},"Here you can see how the Swedish aid has been distributed based on your filter options.","Här kan du snabbt navigera och se hur biståndet har fördelats utifrån de val du har gjort.",{"en":139,"sv":139},{"id":190,"title":191,"description":194,"other_info":197},"export-button",{"en":192,"sv":193},"Export data","Exportera data",{"en":195,"sv":196},"You can export the data in xls-format.","Här kan kan du exportera data i xls-format.",{"en":139,"sv":139},{},{"contribution":200,"activities":335,"paidTransactions":577,"transactions":580,"strategies":583},{"iatiidentifier":201,"reportingorg":202,"title":207,"descriptions":213,"participatingorgs":226,"activitystatus":233,"activitydates":234,"defaultflowtype":240,"contactinfo":241,"recipientCountries":248,"sectors":253,"documentlinks":260,"result":295,"relatedactivities":310,"lastupdateddatetime":313,"lang":264,"defaultcurrency":314,"hierarchy":220,"humanitarianSpecified":12,"hasHumanitarianActivity":12,"hasLongtermActivity":71,"transactionsMetadata":315,"activitiesMetadata":330},"SE-0-SE-6-16785",{"narrative":203,"ref":204,"type":205,"secondaryreporter":206},"Sweden","SE-0",10,0,[208,210],{"value":209},"Vaccines University of Rwanda, EU-Delegation MAV+, and vaccine uptake",{"lang":211,"value":212},"sv","Vaccin University of Rwanda, EU-delegering MAV+ och vaccinacceptans",[214,221],{"narrative":215,"type":220},[216,218],{"value":217},"Contributions to strengthen capacity for vaccine development and production in Rwanda. The main contribution is the implementation of the EU's Global Gateway program Team Europe Initiative \"MAV+\" with the objective of strengthening capacity for vaccine development and production in Rwanda, in collaboration with the University of Rwanda and three Swedish universities, as well as a smaller program with the University of Rwanda for vaccine acceptance research.",{"lang":211,"value":219},"Insatser för att stärka kapaciteten för vaccinutveckling och produktion i Rwanda. Inom ramen för insatserna ingår genomförandet av EU's Global Gateway-program Team Europe Initiative \"MAV+\" med målsättningen att stärka kapacitet för vaccinutveckling och produktion i Rwanda, i samarbete med University of Rwanda och tre svenska universitet, samt en mindre insats med University of Rwanda för forskning om vaccinacceptans.",1,{"narrative":222,"type":225},[223],{"value":224},"Rwanda is leading efforts to transform Africas vaccine manufacturing capacity. Significant progress has been made in building infrastructure, such as Africas first mRNA vaccine manufacturing facility (BioNTech), and strengthening regulatory frameworks, including reaching WHO Maturity Level 3 of the national medical agency (RDFA) and the hosting the African Medical Agency (AMA). However, critical gaps remain in research capacity and clinical trial site maturity.\nSweden, with its expertise in global health, research, and capacity strengthening, is uniquely positioned to support Rwanda in these areas. Targeted investments in research, workforce training, and clinical trial site improvement will complement ongoing donor efforts focused on manufacturing and regulatory strengthening, also part of the Team Europe Initiative (TEI) Manufacturing and Access to Vaccines, Medicines, and Health Technology Products in Africa (MAV). This holistic approach will ensure that vaccines produced in Rwanda meet international standards and address top priority diseases of the continent.\nSida's contribution will be implemented by University of Rwanda (UR) in close cooperation with three Swedish universities (Karolinska Institutet, Göteborg university and Umeå University), as well as with the International Vaccine Institute (IVI), King Faisal Hospital and University of Global Health Equity. \nThe interventions long-term goal is that Rwanda makes an important contribution to the development and manufacturing of Africa's needs of vaccines, medicines and health technologies. Rwanda and Africa at large have a severe shortage of human resources for health, science, and technology. This human resource gap creates a limitation for Rwanda to use and adapt emerging technologies that would have the potential to improve quality of life for Rwandan people, drive socio-economic development and foster sustainable growth. \nVaccines are the most effective way to prevent diseases, protect against serious illness, and are safer than catching diseases, preventing millions of deaths; but only when people are vaccinated. Behavioral and social understanding of vaccine uptake, including hesitancy and practical access, is a still understudied area in Eastern Africa. In a project co-financed with Canadian IDRC, this area will be studied in Rwanda, Kenya, Ethiopia, Uganda and Tanzania. \n\nObjectives of the interventions\nThe overall program objective is Strengthened environment for local pharmaceutical and health technologies production through research, higher education and professional skills development in Rwanda, with the following specific objectives:\n- Strengthened capacity of Rwanda to conduct high-quality in-country research and training in areas related to vaccines;\n- Upgraded clinical trial sites with capacity to conduct complex trials, including the establishment of a Center of Excellence with comprehensive infrastructure, regulatory, and training components to enable high-quality, multisite clinical trials in Rwanda;\n- Enhanced vaccine demand and acceptance in Eastern Africa by generating evidence on social and behavioral determinants, addressing systemic and communication barriers.\n\nBy the end of the intervention, we expect to see 7 new MSc programs and a One PhD program developed and implemented, 100 MSc and 15 PhD graduates and 3 postdocs. We expect more than 60 new peer-reviewed research publications. 4 clinical trial sites are expected to be certified and 7 to be upgraded in their quality management systems, and at least 5 cohorts of clinical trial staff to have been trained. In vaccine uptake, 15 research fellows trained and mentored over the period of 3 years and at least 200 regional researchers and practitioners will receive short training.",2,[227,229],{"narrative":203,"ref":204,"crsChannelCode":228,"type":205,"typeSpecified":71,"role":220},"11001",{"narrative":230,"ref":231,"crsChannelCode":228,"type":205,"typeSpecified":71,"role":232},"Swedish International Development Cooperation Agency","SE-6",3,{"code":225},[235,237,239],{"type":225,"isodate":236},"2025-10-01T00:00:00",{"type":232,"isodate":238},"2029-06-30T00:00:00",{"type":220,"isodate":236},{"code":205},{"organisation":242,"telephone":243,"email":244,"website":245,"mailingaddress":246},{"narrative":230},"+46 8 698 50 00","sida@sida.se","www.sida.se",{"narrative":247},"Box 2025, 174 02 Sundbyberg, Sweden",[249],{"narrative":250,"code":251,"percentage":252},"Rwanda","RW",100,[254,257],{"narrative":255,"code":256,"vocabulary":220,"percentage":252},"Medical research",12182,{"narrative":258,"code":259,"vocabulary":225,"percentage":252},"Health, General",121,[261,270,277,283,289],{"title":262,"category":266,"url":268,"format":269},{"narrative":263},{"lang":264,"value":265},"en","16785_16785A07GrantAgreementforVaccineUptake.pdf",{"code":267},"A04","https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F16785_16785A07GrantAgreementforVaccineUptake.pdf","application\u002Fpdf",{"title":271,"category":274,"url":276,"format":269},{"narrative":272},{"lang":264,"value":273},"16785_16785DecisiononAgreementAmendment2.pdf",{"code":275},"A05","https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F16785_16785DecisiononAgreementAmendment2.pdf",{"title":278,"category":281,"url":282,"format":269},{"narrative":279},{"lang":264,"value":280},"16785_16785A07DecisiononAgreementAmendment1.pdf",{"code":275},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F16785_16785A07DecisiononAgreementAmendment1.pdf",{"title":284,"category":287,"url":288,"format":269},{"narrative":285},{"lang":264,"value":286},"16785_16785Amendment2onGrantAgreementonVaccineResearchwithKI.pdf",{"code":267},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F16785_16785Amendment2onGrantAgreementonVaccineResearchwithKI.pdf",{"title":290,"category":293,"url":294,"format":269},{"narrative":291},{"lang":264,"value":292},"16785_16785A08IVIAgreement.pdf",{"code":267},"https:\u002F\u002Fdocuments.iati.openaid.se\u002Fdocument\u002Frwanda-and-burundi\u002F16785_16785A08IVIAgreement.pdf",{"title":296,"description":301,"indicator":304,"type":225,"aggregationstatus":206},[297,299],{"value":298},"Results achieved",{"lang":211,"value":300},"Uppnådda resultat",[302],{"value":303},"Strengthened capacity in research and training\nThe main intervention of MAV was initiated in August 2024 with an inception phase, followed by the start of the full intervention in March 2025. During this period, the core partners the College of Medicine and Health Sciences at the University of Rwanda (UR), Karolinska Institutet, and the University of Gothenburg have begun to function effectively as a team, building trust, shared understanding, and coordinated ways of working. The recent visit by the main researchers from MAV at the UR to Sweden further strengthened these relationships, offering an opportunity to deepen existing collaborations, establish new ones, and transition from individual to institutional partnerships.\n\nThe project is now entering a new phase, with URs six MSc curricula and the PhD curriculum in translational health fully developed. With the accreditation of the PhD program and the MSc in Clinical Trials, all 15 PhD students, 20 MSc students, and 3 postdocs have been successfully recruited. In addition, private funding has enabled the recruitment of 5 extra PhD and 10 MSc students an unexpected and very encouraging achievement. Demand for the MSc in Clinical Trials has been particularly high, reflecting significant national needs. As a response, we are proposing to the EU to fund an additional cohort, if possible.\n\nThe remaining five MSc programs were submitted to the Higher Education Council (HEC) in February 2026 and are expected to be accredited during the spring. Following accreditation, student recruitment will begin for the next academic year, either in April or September.\n\nIn parallel, supervision training is planned for the coming year, along with a three daylong workshop on intellectual property rights (IPR), being developed by the Embassy jointly with the EUs MAV support function (TESS). Development of the MSc in Bioethics will also take place in the coming year, as part of the newly initiated collaboration with the University of Global Health Equity (UGHE).\n\n\nUpgraded clinical trial sites\nThe first steps toward strengthening Rwandas clinical trial (CT) capacity have been taken through a coordinated, evidence-based, and multi-stakeholder approach. The national clinical trial site-readiness assessment conducted by Rwanda Biomedical Center (RBC) laid the foundation for prioritizing investments under MAV, resulting in the selection of the CT sites at CHUB, CHUK and the Rwanda Military Referral and Teaching Hospital for upgrading. A three-day stakeholder workshop convened representatives from all major national institutions and international partners, leading to alignment of planned activities, a coordinated plan forward, and the definition of roles and responsibilities. The workshop also recommended establishing a steering committee and a technical working group to support coordinated implementation across institutions.\n\nCollaboration with the International Vaccine Institute (IVI) has deepened significantly, with UR, RBC, FDA, IVI, KI, Sida, and Expertise France now working together on detailed plans for site readiness. IVI is positioned to support Rwanda in achieving internationally recognized standards, including ICHGCP and ISO accreditation, and will continue to contribute through technical assistance, Quality management systems (QMS) audits, mentorship, and its established vaccinology courses.\n\nRegional partners such as CDT Africa and AHRI have strengthened Rwandas CT capacity by supporting curriculum review and participating in national consultations. Additional foundational activities outside MAV have further contributed to progress: RBCs site-readiness study guided MAV planning; the SANOFI\u002FIVI\u002FKI initiative trained 22 Rwandan professionals in CT and biomedical research through a train-the-trainer model, providing a skilled cohort ready to support MAV implementation; eligible Rwandan researchers were encouraged to apply for WHOTDR clinical trial fellowships; and a new Rwanda FDA PhD student was registered at Karolinska Institutet with EDCTP funding.\n\nFollowing a mandate from the Rwanda Development Board, a multi-partner proposal for the establishment of a Center of Excellence in Clinical Trials in Rwanda, based at UGHE and King Faisal Hospital, was prepared and approved. Engagements with KFH and UGHE through the stakeholder meeting and field visits have helped build relationships and clarify future collaboration.\n\nOverall, despite delays in some components, the clinical trial team has established solid foundations for the next phase of work.\n\nEnhanced vaccine demand and acceptance in Eastern Africa\nThe initiative to enhance vaccine demand and acceptance in Eastern Africa has progressed from a successful inception phase into full implementation. During the inception phase, institutional ownership was secured, internal stakeholders were aligned, and the university was positioned as a regional hub for behavioral vaccine research. This process identified key capacity gaps and helped establish both a regional research agenda and a network of engaged stakeholders. The proposal was strengthened through multiple expert workshops and a Delphi review involving specialists in gender studies, anthropology of vaccination, intersectionality, and social determinants of health, ensuring a robust conceptual foundation.\n\nUniversities from Ethiopia, Uganda, Kenya, and Tanzania formally joined Rwanda in the initiative, embedding a regionally anchored and South-South collaborative structure. Sida and the Canadian funder IDRC have jointly emphasized the need for close coordination on capacity-strengthening models, training across five countries, and scientific quality assurance.\n\nWith the full program now initiated, the Eastern Africa Hub for Behavioural and Social Science Research and Capacity Strengthening for Vaccine Uptake (EARVU Hub) held its first regional collaboration meeting. Country focal persons from all five partner countries participated, marking a key milestone in operationalizing regionally led coordination. The meeting resulted in agreement on collaboration mechanisms, confirmation of the fellowship selection processes, and clarification of national level roles. Participants validated the core governance and implementation documents for postdoctoral fellowships and small grant awards, ensuring transparency, equity, and scientific rigor. \n",{"title":305,"description":307,"measure":309,"ascending":206},{"narrative":306},"Not applicable",{"narrative":308},"No indicator available - only a description of the activity results is published",5,[311],{"ref":312,"type":225},"SE-0-SE-6-16785-16785A0701","2026-11-11T04:29:29+00:00","SEK",[316],{"accountableOrganisation":317,"thematicAreas":318,"code":232,"agency":231,"aidType":320,"collaborationType":220,"sector":256,"sectorCategory":321,"humanitarian":12,"sdgs":322,"sdgCategories":324,"activity":312,"year":326,"value":327,"recipient":251,"strategy":328,"strategyEndDate":329,"organisation":317},"51000:university_of_rwanda",[319],"poverty-reduction-through-job-creation,-trade-and-education","C01",120,[323],"3.b",[325],"3.0",2025,390647,1140103,"2028-12-31T00:00:00",{"organisations":331},[332],{"role":333,"id":317,"name":334},4,"University of Rwanda",[336],{"iatiidentifier":312,"reportingorg":337,"title":338,"descriptions":342,"participatingorgs":350,"activitystatus":357,"activitydates":358,"tags":362,"policymarkers":369,"collaborationtype":390,"defaultfinancetype":391,"defaultaidtype":393,"defaulttiedstatus":394,"budgets":395,"planneddisbursements":423,"transactions":510,"relatedActivities":529,"strategies":531,"lastupdateddatetime":313,"lang":264,"defaultcurrency":314,"hierarchy":225,"humanitarian":206,"humanitarianSpecified":71},{"narrative":203,"ref":204,"type":205,"secondaryreporter":206},[339,340],{"lang":211,"value":212},{"value":341},"Vaccines University of Rwanda, EU-Delegation MAV+, and vaccine uptake - Vaccine uptake, CASS\u002FUR",[343,347],{"narrative":344,"type":220},[345,346],{"value":217},{"lang":211,"value":219},{"narrative":348,"type":225},[349],{"value":224},[351,352,355,356],{"narrative":203,"ref":204,"crsChannelCode":228,"type":205,"typeSpecified":71,"role":220},{"narrative":334,"crsChannelCode":353,"type":354,"typeSpecified":71,"role":225},"51000",80,{"narrative":230,"ref":231,"crsChannelCode":228,"type":205,"typeSpecified":71,"role":232},{"narrative":334,"crsChannelCode":353,"type":354,"typeSpecified":71,"role":333},{"code":225},[359,360,361],{"type":225,"isodate":236},{"type":232,"isodate":238},{"type":220,"isodate":236},[363],{"narrative":364,"code":323,"vocabulary":232},[365,367],{"lang":211,"value":366},"3.b - Stödja forskning om och utveckling av vaccin och läkemedel mot de smittsamma och icke-smittsamma sjukdomar som i första hand drabbar utvecklingsländer. Sörja för tillgång till ekonomiskt överkomliga grundläggande läkemedel och vaccin, i enlighet med Doha-deklarationen om TRIPS-avtalet och folkhälsa, i vilken det bekräftas att utvecklingsländerna har rätt att fullt ut utnyttja den flexibilitet som avtalet om handelsrelaterade aspekter av immaterialrätter erbjuder för att skydda folkhälsan och, framför ",{"value":368},"3.b - Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public healt",[370,372,374,376,379,382,385,387],{"narrative":371,"code":220,"vocabulary":220,"significance":206},"Gender Equality",{"narrative":373,"code":225,"vocabulary":220,"significance":206},"Aid to Environment",{"narrative":375,"code":309,"vocabulary":220,"significance":206},"Aid Targeting the Objectives of the Convention on Biological Diversity",{"narrative":377,"code":378,"vocabulary":220,"significance":206},"Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation",6,{"narrative":380,"code":381,"vocabulary":220,"significance":206},"Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation",7,{"narrative":383,"code":384,"vocabulary":220,"significance":206},"Aid Targeting the Objectives of the Convention to Combat Desertification",8,{"narrative":386,"code":205,"vocabulary":220,"significance":206},"Disaster Risk Reduction(DRR)",{"narrative":388,"code":389,"vocabulary":220,"significance":206},"Disability",11,{"code":220},{"code":392},110,{"code":320},{"code":309},[396,402,409,416],{"periodstart":397,"periodend":399,"value":401},{"isodate":398},"2025-01-01T00:00:00",{"isodate":400},"2025-12-28T00:00:00",{"valuedate":398,"value":327},{"periodstart":403,"periodend":405,"value":407},{"isodate":404},"2026-01-01T00:00:00",{"isodate":406},"2026-12-28T00:00:00",{"valuedate":404,"value":408},1459353,{"periodstart":410,"periodend":412,"value":414},{"isodate":411},"2027-01-01T00:00:00",{"isodate":413},"2027-12-28T00:00:00",{"valuedate":411,"value":415},2300000,{"periodstart":417,"periodend":419,"value":421},{"isodate":418},"2028-01-01T00:00:00",{"isodate":420},"2028-12-28T00:00:00",{"valuedate":418,"value":422},350000,[424,429,434,439,444,449,455,460,464,469,474,480,485,490,495,500,505],{"periodstart":425,"periodend":426,"value":427},{"isodate":398},{"isodate":400},{"valuedate":428,"value":206},"2025-09-01T00:00:00",{"periodstart":430,"periodend":431,"value":432},{"isodate":404},{"isodate":406},{"valuedate":433,"value":206},"2026-06-01T00:00:00",{"periodstart":435,"periodend":436,"value":437},{"isodate":404},{"isodate":406},{"valuedate":438,"value":206},"2026-05-01T00:00:00",{"periodstart":440,"periodend":441,"value":442},{"isodate":404},{"isodate":406},{"valuedate":443,"value":408},"2026-11-01T00:00:00",{"periodstart":445,"periodend":446,"value":447},{"isodate":398},{"isodate":400},{"valuedate":448,"value":327},"2025-11-01T00:00:00",{"periodstart":450,"periodend":451,"value":452},{"isodate":411},{"isodate":413},{"valuedate":453,"value":454},"2027-10-01T00:00:00",600000,{"periodstart":456,"periodend":457,"value":458},{"isodate":418},{"isodate":420},{"valuedate":459,"value":206},"2028-02-01T00:00:00",{"periodstart":461,"periodend":462,"value":463},{"isodate":398},{"isodate":400},{"valuedate":236,"value":206},{"periodstart":465,"periodend":466,"value":467},{"isodate":404},{"isodate":406},{"valuedate":468,"value":206},"2026-02-01T00:00:00",{"periodstart":470,"periodend":471,"value":472},{"isodate":404},{"isodate":406},{"valuedate":473,"value":206},"2026-08-01T00:00:00",{"periodstart":475,"periodend":476,"value":477},{"isodate":411},{"isodate":413},{"valuedate":478,"value":479},"2027-05-01T00:00:00",1700000,{"periodstart":481,"periodend":482,"value":483},{"isodate":411},{"isodate":413},{"valuedate":484,"value":206},"2027-02-01T00:00:00",{"periodstart":486,"periodend":487,"value":488},{"isodate":404},{"isodate":406},{"valuedate":489,"value":206},"2026-09-01T00:00:00",{"periodstart":491,"periodend":492,"value":493},{"isodate":404},{"isodate":406},{"valuedate":494,"value":206},"2026-10-01T00:00:00",{"periodstart":496,"periodend":497,"value":498},{"isodate":418},{"isodate":420},{"valuedate":499,"value":422},"2028-04-01T00:00:00",{"periodstart":501,"periodend":502,"value":503},{"isodate":404},{"isodate":406},{"valuedate":504,"value":206},"2026-12-01T00:00:00",{"periodstart":506,"periodend":507,"value":508},{"isodate":411},{"isodate":413},{"valuedate":509,"value":206},"2027-09-01T00:00:00",[511,520],{"transactiontype":512,"transactiondate":513,"value":514,"sector":516,"recipientcountry":519},{"code":225},{"isodate":236},{"valuedate":236,"value":515},4500000,[517,518],{"vocabulary":225,"code":259},{"vocabulary":220,"code":256},{"code":251},{"transactiontype":521,"transactiondate":522,"value":524,"sector":525,"recipientcountry":528},{"code":232},{"isodate":523},"2025-11-28T00:00:00",{"valuedate":523,"value":327},[526,527],{"vocabulary":225,"code":259},{"vocabulary":220,"code":256},{"code":251},[530],{"ref":201,"type":220},{"strategy":532},{"title":533,"strategyObjective":538,"code":328,"strategystartdate":576,"strategyenddate":329,"strategyamount":206,"currency":314},[534,536],{"value":535},"Research cooperation 2022-2028",{"lang":211,"value":537},"Forskningssamarbete 2022-2028",[539,553,565],{"name":540,"thematicArea":545,"code":551,"percentage":552},[541,543],{"value":542},"Enhanced research capacity and sustainable research environments (Sida)",{"lang":211,"value":544},"Stärkt forskningskapacitet och hållbara forskningsmiljöer (Sida)",{"narrative":546},[547,549],{"value":548},"Poverty reduction through job creation, trade and education",{"lang":211,"value":550},"Fattigdomsbekämpning genom jobbskapande, handel och utbildning","FORSK2022a1",50,{"name":554,"thematicArea":559,"code":563,"percentage":564},[555,557],{"value":556},"Enhanced global, regional and national research that is of relevance to the least developed countries and regions (Sida)",{"lang":211,"value":558},"Stärkt global, regional och nationell forskning av relevans för minst utvecklade länder och regioner (Sida)",{"narrative":560},[561,562],{"value":548},{"lang":211,"value":550},"FORSK2022a2",25,{"name":566,"thematicArea":571,"code":575,"percentage":564},[567,569],{"value":568},"Enhanced impact of research that is of relevance to poverty reduction and sustainable development (Sida)",{"lang":211,"value":570},"Stärkt genomslag för forskning av relevans för fattigdomsbekämpning och hållbar utveckling (Sida)",{"narrative":572},[573,574],{"value":548},{"lang":211,"value":550},"FORSK2022a3","2022-10-01T00:00:00",[578],{"type":232,"transactionDate":326,"valueDate":579,"value":327,"recipientcountry":528,"recipientregion":139,"sector":525},["Date","2025-11-27T23:00:00.000Z"],[581,578],{"type":225,"transactionDate":326,"valueDate":582,"value":515,"recipientcountry":519,"recipientregion":139,"sector":516},["Date","2025-09-30T22:00:00.000Z"],[532],{"links":585,"preamble":639,"dateObject":642},[586,594,603,612,621,630],{"id":587,"title":588,"slug":591,"post_id":564,"children":139,"description":139,"description_title":139,"description_swe":139,"description_title_swe":139,"localization":592},216,{"en":589,"sv":590},"About Openaid","Om Openaid","about-openaid",{"sv_slug":593},"om-openaid",{"id":595,"title":596,"slug":599,"post_id":600,"children":139,"description":139,"description_title":139,"description_swe":139,"description_title_swe":139,"localization":601},9424,{"en":597,"sv":598},"Contacts","Kontakt","about-openaid\u002Fcontact",49,{"sv_slug":602},"om-openaid\u002Fkontakt",{"id":604,"title":605,"slug":608,"post_id":609,"children":139,"description":139,"description_title":139,"description_swe":139,"description_title_swe":139,"localization":610},221,{"en":606,"sv":607},"Publications","Publikationer","about-openaid\u002Fpublications",158,{"sv_slug":611},"om-openaid\u002Fpublikationer",{"id":613,"title":614,"slug":617,"post_id":618,"children":139,"description":139,"description_title":139,"description_swe":139,"description_title_swe":139,"localization":619},217,{"en":615,"sv":616},"Accessibility of Openaid","Tillgänglighetsredogörelse","about-openaid\u002Faccessibility-of-openaid",156,{"sv_slug":620},"om-openaid\u002Ftillganglighetsredogorelse",{"id":622,"title":623,"slug":626,"post_id":627,"children":139,"description":139,"description_title":139,"description_swe":139,"description_title_swe":139,"localization":628},220,{"en":624,"sv":625},"Privacy notice","Behandling av personuppgifter","about-openaid\u002Fprivacy-notice",42,{"sv_slug":629},"om-openaid\u002Fbehandling-av-personuppgifter",{"id":631,"title":632,"slug":635,"post_id":636,"children":139,"description":139,"description_title":139,"description_swe":139,"description_title_swe":139,"localization":637},222,{"en":633,"sv":634},"Report suspicions of corruption, irregularities, and misconduct","Anmäl misstankar om korruption","about-openaid\u002Freport-suspicions-of-corruption-irregularities-and-misconduct",47,{"sv_slug":638},"om-openaid\u002Fanmal-misstankar-om-korruption-oegentligheter-och-missforhallanden",{"en":640,"sv":641},"Openaid publishes information from agencies and departments in accordance with the transparency guarantee.","På Openaid publiceras information från myndigheter och departement i enlighet med transparensgarantin.",{"lastImport":643,"generatedDate":644},"2026-11-11T07:25:00.211818","2026-11-11T04:29:23+00:00"]